Lixte Biotechnology Announces a Clinical Trial Agreement with Moffitt Cancer Center to Initiate Phase 1b/2 Trial Evaluating the Safety and Efficacy of LB-100 in Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome
Apple introduces MacBook Pro with all-new M5 Pro and M5 Max, delivering breakthrough pro performance and next-level on-device AI
